IMMUNO-THERATRACE Trademark

Trademark Overview

On Monday, December 12, 2022, a trademark application was filed for IMMUNO-THERATRACE with the United States Patent and Trademark Office. The USPTO has given the IMMUNO-THERATRACE trademark a serial number of 97713776. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, October 16, 2024. This trademark is owned by Melior Discovery, Inc.. The IMMUNO-THERATRACE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research; pharmaceutical research services; testing of pharmaceuticals; contract research services, namely, pharmaceutical contract research services
immuno-theratrace

General Information

Serial Number97713776
Word MarkIMMUNO-THERATRACE
Filing DateMonday, December 12, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements

Goods and Servicesscientific research; pharmaceutical research services; testing of pharmaceuticals; contract research services, namely, pharmaceutical contract research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 9, 2023
Primary Code042
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

Trademark Owner History

Party NameMelior Discovery, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressExton, PA 19341
Party NameMelior Discovery, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressExton, PA 19341

Trademark Events

Event DateEvent Description
Thursday, December 15, 2022NEW APPLICATION ENTERED
Monday, January 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 15, 2023ASSIGNED TO EXAMINER
Thursday, October 5, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, October 5, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, October 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 5, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, October 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 6, 2023WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Tuesday, October 10, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, October 10, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 10, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, October 10, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 10, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, October 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024USE AMENDMENT FILED
Tuesday, July 9, 2024SOU EXTENSION 1 FILED
Tuesday, July 9, 2024SOU EXTENSION 1 GRANTED
Tuesday, September 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 11, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, October 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Related Keywords

theratrace immuno research services contract pharmaceutical namely testing scientific pharmaceuticals